Cromwell Holdings’s Axsome Therapeutics AXSM Stock Holding History

Cromwell Holdings’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.69K	Buy	+11	New	+$2.39K	﹤0.01%	788

Other funds holding AXSM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

TAM

Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

Cromwell Holdings's AXSM Position: Q2 2026 in Review

Cromwell Holdings opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 11 shares worth $2.69K. The stake represents ﹤0.01% of the portfolio and ranks #788 among its holdings.

53 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Cromwell Holdings held 11 shares of Axsome Therapeutics worth $2.69K as of Q2 2026.
Axsome Therapeutics was a new Cromwell Holdings position in Q2 2026.
Axsome Therapeutics made up ﹤0.01% of Cromwell Holdings's portfolio in Q2 2026, its #788 holding.
53 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.